Fox Chase Cancer Center News

PHILADELPHIA (June 27, 2017) – It is important that all patients who have completed cancer treatment have a wellness plan in place as they transition from treatment to recovery.

Modern Healthcare writes that those on the list “stand out for the scope of their executive responsibilities, personal achievements, innovation and commitment to their communities.”

PHILADELPHIA (June 6, 2017) - It is with great respect that we remember and pay tribute to an admired colleague and friend, a luminary in his field, and a noted figure within Fox Chase Cancer Center’s legacy. We join you in mourning the loss of W. Thomas London, MD, Professor Emeritus, on Saturday, June 3, following an apparent heart attack. He was 85 years old.

PHILADELPHIA (June 2, 2017) - Martin J. Edelman, MD, FACP, chair of Hematology/Oncology at Fox Chase Cancer Center, presented the results of a clinical study testing palbociclib at the American Society of Clinical Oncology annual meeting in Chicago. Of the 32 patients evaluated, only two responded to the drug, showing it to be ineffective on its own for patients with squamous NSCLC.

PHILADELPHIA (June 1, 2017) - Approximately 200 students from five area high schools will come together at Fox Chase Cancer Center on June 5 to present data they gathered through the Center’s Immersion Science Program.

PHILADELPHIA (May 16, 2017) – Fox Chase Cancer Center is pleased to announce the arrival of Roman Petrov, MD, who will join the faculty as assistant professor in the division of thoracic surgery. He will concurrently serve as assistant professor of thoracic medicine and surgery at the Lewis Katz School of Medicine at Temple University. Dr. Petrov's clinical interests include Lung and Esophageal cancer, benign foregut diseases and chest wall tumors and deformities, including Thoracic outlet syndrome.

​PHILADELPHIA, PA (May 15, 2017) – Springside Chestnut Hill Academy has awarded Rosaleen B. Parsons, MD, its Distinguished Alumnae Award. Parsons is chair of the Department of Diagnostic Imaging at Fox Chase Cancer Center, where she has worked since 1999.

PHILADELPHIA (May 15, 2017) – Medical oncologists Lori Goldstein, MD, and Elias Obeid, MD, MPH, are opening a phase 2 immunotherapy clinical trial for newly diagnosed, locally recurrent, or metastatic HER2-overexpressing breast cancer.